The Contribution of Innovation to Health Care Costs: At Least 50%? by Rosa M. Abrantes-Metz (Global Economics Group, LLC; New York University – Leonard N. Stern School of Business – Department of Economics)
Abstract:
This paper is primarily concerned with estimating an upper bound for the contribution of technological progress on health care costs as motivated by the recent debate on U.S. health care reform. We critically address whether technology is at least 50% of the increase in health care costs as proposed recently in the literature. The desire to reduce costs in the health care system combined with estimates that technological change is the major contributor to those costs has led some to propose policies with the ultimate effect of discouraging innovation in health care technology. In this paper we show that more appropriate econometric procedures lead to estimates of technology’s role in health care costs which are significantly less than other published results.
Using only U.S. time-series data we estimate an upper bound for the contribution of innovation to health care costs. Our model follows that of the Congressional Budget Office’s (CBO) 2008 report and uses identical data, but finds that the contribution of technological progress is 32.3% – significantly smaller than what the CBO estimates. Even this value can only represent an upper bound, as there remain important factors which have been omitted from the study primarily due to data unavailability.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI